Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Sep 1.

Published in final edited form as: Eur J Pharm Biopharm. 2019 Aug 6;142:543–552. doi: 10.1016/j.ejpb.2019.08.004

Fig. 4. — Antibacterial activities of ciprofloxacin (80 μg/mL for strain FADD1-PA001 and 40 μg/mL for JIP865), PEV20 (10⁵ PFU/mL for strain FADD1-PA001 and 10⁶ PFU/mL for JIP865), and spray dried combinations before and after unit dose test using low (a) and high (b) resistance Osmohaler™ (n=6).

Fig. 4. — Antibacterial activities of ciprofloxacin (80 μg/mL for strain FADD1-PA001 and 40 μg/mL for JIP865), PEV20 (10⁵ PFU/mL for strain FADD1-PA001 and 10⁶ PFU/mL for JIP865), and spray dried combinations before and after unit dose test using low (a) and high (b) resistance Osmohaler™ (n=6).